The patients were being administered paracetamol, and not Remdesivir drug, which was used for patients in the first and second COVID-19 waves, they said.
If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.
With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.
Rs 100 crore funds have been allocated towards genetic disorders.
A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.
Nadella's visit comes at a time when the Indian government is taking a strong position on issues like data localisation and tightening the rules for e-commerce companies as well as social media platforms.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
'Wearing masks, washing our hands, all those things are barriers to transmissibility, or contagion, but as the virus becomes more contagious it statistically is better at getting around those barriers'
The CIC's order of April 13 had also directed DBT to disclose bio-safety data of rice, okra (lady's finger) and mustard, after an Right to Information application was filed by Greenpeace activist Divya Raghunandan.
'There is no data to show this virus is more deadlier.'
The study, published in the Journal of Clinical Investigation, also demonstrates that the immunity built up from previous non-SARS-CoV-2 coronavirus infections does not prevent individuals from getting COVID-19.
'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'
The United States intelligence community has failed to reach any firm conclusion on the exact origin of COVID-19 and is split on whether it leaked from a lab in China or emerged in nature, even though it does not believe the virus was developed as a biological weapon, according to results of a detailed review ordered by President Joe Biden.
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
Using this sequence data, the researchers traced the origins and evolution of SARS-CoV-2 by focusing on the tell-tale features of the virus.
Abhik Sen, who tried out the new service, finds out it is good for data and apps, but calls are still sketchy
The South African authorities said the detected cases and percentage of people testing positive are both increasing quickly, particularly in particularly in most populated province of Gauteng, North West and Limpopo regions of the country.
More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.
The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.
Centre for Sustainable Agriculture has leveled serious charges against Genetic Engineering Approval Committee for allowing large-scale field trials of Bt Brinjal.
The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.
Adding 20 minutes to a daily walk and increasing vigorous daily activity by eight minutes would be enough to achieve a lower sleep apnea risk, a study has revealed.
The Covid-19 vaccine demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials, reports Sohini Das
'Scientifically the effect and change of Delta plus has to be watched through our INSACOG system. This has to be detected and we have to see its presence in the country'
Pune's Mylab Discovery Solutions' CoviSelf, which gives results in 15 minutes, gets ICMR nod
In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.
'No matter how much the political pressure is, I cannot say I will bring the Moon for you tomorrow!'
'Two years ago, had I been given even a tiny hint that my genes were tipping the scale for the development of a disease that would lock me into my body, unable to move or breath normally on my own, I would have been sad, and probably mad.' 'So now I'm running as fast as I can -- from my wheelchair.' P Rajendran on the amazing but brief life of Rahul Desikan, medical pioneer.
Explaining how RT-PCR tests may yield a false negative results, the scientists said, when a swab misses collecting cells infected with the virus, or if virus levels are very low early during the infection, some tests can produce negative results.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
The White House described the development as "quite good news".
Researchers from Huazhong University of Science and Technology in China assessed data on 938 COVID-19 patients from the country's Wuhan Union Hospital. They obtained information about residual symptoms in these patients, and the results of follow up tests for viral genetic material in their body after they were discharged.
'We still have 30,000-40,000 cases.' 'It is plateauing, but the number should definitely come down more so that we can convert the pandemic into an endemic.'
The United Kingdom on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus.
However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.
'If we take such an approach, we may find ourselves in a tough situation.' 'COVID-19 doesn't spread through water or air or mosquito; it only spreads from person to person.' 'We should make wearing a mask as part of our life.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances